Recombinant Human PCSK9/Proprotein Convertase 9
- 发布日期: 2017-06-23
- 更新日期: 2026-01-28
产品详请
| 产地 |
北京
|
| 品牌 |
solarbio
|
| 货号 |
P00123
|
| 保存条件 |
Store at < -20癈, stable for 6 months after receipt. Please minimize freeze-thaw cycles.
|
| 保质期 |
3个月个月
|
简介:Recombinant Human Proprotein Convertase Subtilisin/Kexin Type 9 is produced by our Mammalian expression system and the target gene encoding Gln31-Gln152&Ser153-Gln692 is expressed with a 6His tag at the C-terminus.
种属:Human
表达系统:Human cells
Endotoxin:Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test.
storage:Store at < -20°C, stable for 6 months after receipt.
Please minimize freeze-thaw cycles.
Background:Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER , the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2), and play a role in the neural development.